US2008207439A1PendingUtilityA1
Hydrogenation of imine intermediates of sertraline with catalysts
Est. expiryApr 14, 2023(expired)· nominal 20-yr term from priority
B01J 23/75C07C 209/52A61P 25/24B01J 35/60B01J 35/613B01J 35/647
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are hydrogenation processes of sertraline imine intermediates with catalysts in various reactors.
Claims
exact text as granted — not AI-modified1 . A process for preparing a cobalt catalyst suitable for reduction of sertraline-1-imine comprising the steps of:
a) calcining an alumina-silica support; b) evaporating moisture from the calcined support; c) contacting the calcined support with an aqueous solution of cobalt nitrate to saturate the surface of the support to obtain a catalyst; d) drying the catalyst; and e) calcining the catalyst in the presence of hydrogen to obtain an oxidation state of CoO.
2 . The process of claim 1 , wherein the calcining is carried out by heating to a temperature of at least about 450° C.
3 . The process of claim 2 , wherein the temperature is about 500° C.
4 . The process of claim 1 , wherein evaporating is carried out under reduced pressure.
5 . The process of claim 1 , wherein the drying is carried out of about 100° C. to about 140° C.
6 . The process of claim 5 , wherein the temperature is about 120° C.
7 . The process of claim 1 , wherein the hydrogen is added to a reactor at a rate of about GHSV 2000 h −1 to about 3000 h −1 .
8 . The process of claim 7 , wherein the hydrogen is added at a rate of about GHSV 2500 per hour.
9 . The catalyst prepared by the process of claim 1 .Join the waitlist — get patent alerts
Track US2008207439A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.